||Welcome to MRI Technology••
|Nonionic Intravenous Contrast Agents || |
|Radiographic low-osmolar nonionic contrast agents have less side effects and fewer nephrotoxicity than ionic, high-osmolar agents. Gadolinium-based MRI contrast agents have a different formulation from iodinated X-ray contrast media, and there is no known cross sensitivity between these two types of contrast agents. Intravenous MRI contrast agents, specifically the gadolinium chelates have a high safety and lack of nephrotoxicity compared with X-ray contrast media.|
The used gadolinium chelates differ in following properties: linear (e.g., gadodiamide and gadoversetamide have nonionic linear structures) vs. macrocyclic cores, and ionic vs. nonionic types. The nonionic molecules have lower osmolality and viscosity, which increase digestibility at greater concentrations, and make faster bolus injections conceivable.
The macrocyclic molecules (e.g., gadoteridol has a nonionic macrocyclic ring structure) are more stable and show fewer tendencies to dissociate free Gd.
See also ProHance®, Omniscan®, OptiMARK®, Ionic Intravenous Contrast Agents.
See also the related poll result: 'MRI will have replaced 50% of x-ray exams by'
• View the DATABASE results for 'Nonionic Intravenous Contrast Agents' (4).
| [last update: 2018-03-08 05:11:00]|